Lilly, Boehringer Ingelheim to co-market duloxetine
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), approved in more than 70 countries in Europe, Latin America and in the United States, for the treatment of major dep...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
